Condition	Treat with 450 uL media containing:
Control (DMOS & IgG1)	0.2% DMSO and 20 μg/ml IgG1
FX	1 μg/ml 5FU + 1 μg/ml oxaliplatin + 20 μg/ml IgG1
FI	1 μg/ml 5FU + 2 μg/ml irinotecan + 20 μg/ml IgG1
PD-1	20 μg/ml ⟨PD-1 + 0.2% DMSO
TIM-3	20 μg/ml ⟨TIM-3 + 0.2% DMSO
FX and PD-1	1 μg/ml 5FU + 1 μg/ml oxaliplatin + 20 μg/ml ⟨PD-1
FX and TIM-3	1 μg/ml 5FU + 1 μg/ml oxaliplatin + 20 μg/ml ⟨TIM-3
FI and PD-1	1 μg/ml 5FU + 2 μg/ml irinotecan + 20 μg/ml ⟨PD-1
FI and TIM-3	1 μg/ml 5FU + 2 μg/ml irinotecan + 20 μg/ml ⟨TIM-3
STS	10 μM STS and 20 μg/ml IgG1